Natixis’s NEVRO CORP. NVRO Stock Holding History

Natixis’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,500	Closed	-$663K	–	1202
2023 Q3	$663K	Buy	34,500 +7,500	+28%	+$160K	0.01%	564
2023 Q2	$686K	Buy	27,000 +22,750	+535%	+$657K	0.01%	599
2023 Q1	$154K	Buy	+4,250	New	+$149K	﹤0.01%	765
2022 Q1	–	Sell	-33,900	Closed	-$2.75M	–	1357
2021 Q4	$2.75M	Buy	33,900 +5,000	+17%	+$501K	0.01%	685
2021 Q3	$3.36M	Sell	28,900 -46,000	-61%	-$6.02M	0.01%	630
2021 Q2	$12.4M	Buy	+74,900	New	+$11.7M	0.05%	246
2021 Q1	–	Sell	-13,800	Closed	-$2.39M	–	1207
2020 Q4	$2.39M	Buy	+13,800	New	+$2.23M	0.01%	653
2017 Q4	–	Sell	-3,443	Closed	-$313K	–	1228
2017 Q3	$313K	Buy	+3,443	New	+$295K	﹤0.01%	879

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Natixis's NVRO Position: Q4 2023 in Review

Natixis sold out of NEVRO CORP. (NVRO) in Q4 2023, closing a stake of 34,500 shares — an estimated $663K sold.

Natixis first reported a position in NVRO in Q3 2017 and held it in 8 quarters. The position peaked at $12.4M in Q2 2021. 140 funds tracked by Wall St. Rank hold NVRO as of Q4 2023.

Natixis reported no remaining NEVRO CORP. position as of Q4 2023 after selling out during the quarter.
Natixis sold 34,500 NEVRO CORP. shares in Q4 2023, an estimated $663K.
Natixis first reported a position in NEVRO CORP. in Q3 2017 and held it in 8 quarters.
Natixis's NEVRO CORP. position peaked at $12.4M in Q2 2021.
140 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2023.

Based on Natixis's 13F filing for Q4 2023, filed 13 Feb 2024.